Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-03-13

Clinical Trial Update: Vaccine Prevention of Rabies Adopts 4-shot Immunization Method [Phase 3]

View source ↗

Summary

A Phase 3 trial update reports a 4-shot immunization method for rabies vaccine prevention has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Changchun Zhuoyi Biological Co., Ltd | Conditions: Rabies Human, Antibody Titer | Phase 3 | Status: COMPLETED